The PERMIT project aims to build recommendations for robust and reproducible personalised medicine research. A first stage of the project focuses on performing a review of existing literature to map existing methodologies and identify gaps and opportunities for recommendations. The protocol for this scoping review project has been made publicly available, and now an abstract of this methodology has been published in a special issue of the Cochrane Library, entitled Advances in Evidence Synthesis. This abstract was submitted by the PERMIT project for the Cochrane Colloquium 2020, but due to the COVID-19 pandemic this event was postponed until September 2022. The abstract was nevertheless selected by the organizers to be part of this special edition and can be found online (p403).

@EatrisEric
Mar 31st
What sample sizes are needed for patient stratification in #PersonalisedMedicine? elixir_lu & IRSJD_info, #ParcSanitariSJD united under the #PERMITproject invite experts to shed light on this question.
👉 Learn more about the specific study factors herpermit-eu.org/article/how-ma…tKS https://t.co/HAom9CCxJl


@ICPerMed
Mar 30th

@ECRIN_ERIC
Mar 30th
The #PERMITproject workshop concluded that no generic approach to #samplesize estimation in #personalisedmedicine can be recommended, but that study-specific considerations are needed: permit-eu.org/article/how-ma…